Actively Recruiting
Quantum Menstrual Health Monitoring Study
Led by Quanovate Tech Inc. · Updated on 2024-10-28
150
Participants Needed
1
Research Sites
104 weeks
Total Duration
On this page
Sponsors
Q
Quanovate Tech Inc.
Lead Sponsor
P
Patricia Doyle-Baker
Collaborating Sponsor
AI-Summary
What this Trial Is About
The Quantum Menstrual Health Monitoring Study will measure four key reproductive hormones in the urine to characterize patterns that predict and confirm ovulation, referenced to serum hormones and the gold-standard of the ultrasound day of ovulation in participants with regular cycles. These normal cycles will provide a reference for comparison to irregular cycles in polycystic ovarian syndrome (PCOS) and athletes. Clinical signs in the menstrual cycle (e.g. menstrual bleeding, temperature) as well as vital sign and sleep patterns will also be referenced to hormonal changes.
CONDITIONS
Official Title
Quantum Menstrual Health Monitoring Study
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Regularly menstruating, PCOS or athlete participants aged 18-45
- Negative pregnancy test at the beginning and at the end of each cycle
- Cycle lengths 24-34 days
- Knowledge of previous 3 cycle lengths
- Able to travel to Calgary Clinic for regular ultrasounds during the study period
You will not qualify if you...
- For regular cycles: Anovulation in the last 3 cycles
- For regular cycles: Currently or in the previous 3 months, on medications that impair or stimulate ovulation (e.g., oral contraceptives, ovulation stimulants)
- For regular cycles: Known conditions impairing ovulation or fertility including polycystic ovarian syndrome, endometriosis, pelvic inflammatory disease in the last year, pituitary adenomas, exclusively breastfeeding
- For regular cycles: Previous surgeries impacting menstrual cycle such as hysterectomy, bilateral oophorectomy
- For regular cycles: Currently pregnant
- For PCOS and athlete groups: Currently or in the previous 3 months, on medications that impair or stimulate ovulation (e.g., oral contraceptives, ovulation stimulants)
- For PCOS and athlete groups: Known conditions impairing ovulation or fertility including pelvic inflammatory disease in the last year, pituitary adenomas, exclusive breastfeeding
- For PCOS and athlete groups: Previous surgeries impacting menstrual cycle such as hysterectomy, bilateral oophorectomy
- For PCOS and athlete groups: Currently pregnant
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Thomas Bouchard
Calgary, Alberta, Canada, T3H 0N9
Actively Recruiting
Research Team
T
Thomas P Bouchard, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here